Clinical Trials Logo

Clinical Trial Summary

A First in man study to evaluate the safety and efficacy of thoracoabdominal aortic stent system for endovascular treatment of thoracoabdominal aortic aneurysms.


Clinical Trial Description

The study is mainly for patients with Crawford type I-V thoracoabdominal aortic aneurysms, and all subjects who passed the screening and signed the informed consent will be enrolled. Patients who meet all the inclusion criteria and don't meet the exclusion criteria will be implanted with thoracoabdominal aortic stent system. Patients will be followed up at discharge, 1 month, 6 months, 12 months after the implantation. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04731636
Study type Interventional
Source Lifetech Scientific (Shenzhen) Co., Ltd.
Contact Wei Xu
Phone 15695219339
Email xuwei@lifetechmed.com
Status Recruiting
Phase N/A
Start date June 20, 2019
Completion date March 31, 2022

See also
  Status Clinical Trial Phase
Recruiting NCT05054985 - Safety and Efficacy of a Multi-branched Thoracoabdominal Stent Graft System for Thoracoabdominal Aortic Aneurysm. N/A
Completed NCT03246126 - Visceral Manifold Study for the Repair of Thoracoabdominal Aortic Aneurysms N/A
Completed NCT02327611 - CUstodiol Versus RInger: whaT Is the Best Agent? Phase 4
Active, not recruiting NCT03075748 - Visceral Manifold Study for the Repair of TAAA N/A
Completed NCT05266781 - A PROpensity Score Matching Analysis on ENDovascular vs Open Thoraco-Abdominal Aortic Aneurysm Repair (PRO-ENDO TAAA Study)